Caris Life Sciences Statistics
Total Valuation
CAI has a market cap or net worth of $5.05 billion. The enterprise value is $5.39 billion.
Market Cap | 5.05B |
Enterprise Value | 5.39B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
CAI has 297.11 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 297.11M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 11.16 |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 11.92 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | 0.71 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.74 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | $255,793 |
Profits Per Employee | -$209,813 |
Employee Count | 1,769 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CAI had revenue of $452.50 million and -$371.16 million in losses. Loss per share was -$1.25.
Revenue | 452.50M |
Gross Profit | 209.73M |
Operating Income | -222.85M |
Pretax Income | -371.16M |
Net Income | -371.16M |
EBITDA | -180.12M |
EBIT | -225.78M |
Loss Per Share | -$1.25 |
Balance Sheet
The company has $34.93 million in cash and $376.74 million in debt, giving a net cash position of -$341.81 million or -$1.15 per share.
Cash & Cash Equivalents | 34.93M |
Total Debt | 376.74M |
Net Cash | -341.81M |
Net Cash Per Share | -$1.15 |
Equity (Book Value) | -2.60B |
Book Value Per Share | -8.75 |
Working Capital | 8.68M |
Cash Flow
In the last 12 months, operating cash flow was -$202.61 million and capital expenditures -$9.40 million, giving a free cash flow of -$212.01 million.
Operating Cash Flow | -202.61M |
Capital Expenditures | -9.40M |
Free Cash Flow | -212.01M |
FCF Per Share | -$0.71 |
Margins
Gross margin is 46.35%, with operating and profit margins of -49.25% and -82.02%.
Gross Margin | 46.35% |
Operating Margin | -49.25% |
Pretax Margin | -82.02% |
Profit Margin | -82.02% |
EBITDA Margin | -39.81% |
EBIT Margin | -49.90% |
FCF Margin | -46.85% |
Dividends & Yields
CAI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -7.35% |
FCF Yield | -4.20% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |